NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN
This announcement does not constitute an offering circular and nothing herein contains an offering of securities.
With reference to the offering circular published by Orphazyme A/S ("Orphazyme") on 6 November 2017 and company announcement no. 4/2017 dated 16 November 2017 regarding the result of the initial public offering and the admission to trading and official listing of shares in Orphazyme on Nasdaq Copenhagen A/S (the "Offering"), Orphazyme has received notification regarding the beginning of the stabilisation period from Danske Bank A/S acting as stabilising manager in the Offering. Reference is made to the attached announcement from Danske Bank A/S.
For additional information, please contact
Anders Hinsby, CEO+45 31 44 31 39
Michael Steen-Knudsen+45 25 17 18 15